Sex Selection and Asia's "Missing Girls"
By Michelle Chen,
Asia Pacific Forum, WBAI
| 07. 11. 2011
[MP3 audio; with CGS's Marcy Darnovsky]
We often hear about sex selective abortion as an issue that is confined to India and China. New research suggests that with 163 "missing girls" lost to "son preference," the problem is not only persisting in Asia but even creeping up in Asian American communities as well. So what are the social, cultural, economic and technological factors that are driving this phenomenon and what are the consequences?
We'll talk with Marcy Darnovsky of the Center for Genetics and Society and Sujatha Jesudason of Generations Ahead about what grassroots groups are doing to confront this issue in their communities here and abroad.
Guests
- Marcy Darnovsky is the Associate Executive Director of the Berkeley-based Center for Genetics and Society.
- Sujatha Jesudason, Executive Director of Generations Ahead
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...